Basic Information
| LncRNA/CircRNA Name | F630028O10Rik |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung cancer |
| ICD-0-3 | C34 |
| Methods | qRT-PCR, Western blot |
| Sample | lung cancer tissues,cell line,blood |
| Expression Pattern | up-regulated |
| Function Description | inhibiting miR-223-3p results in the down-regulation of VEGFA and VEGFR2 which are vital molecules for angiogenesis. |
| Pubmed ID | 32052546 |
| Year | 2019 |
| Title | A novel tumour suppressor lncRNA F630028O10Rik inhibits lung cancer angiogenesis by regulating miR-223-3p |
External Links
| Links for F630028O10Rik | GenBank HGNC NONCODE |
| Links for lung cancer | OMIM COSMIC |